From: Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Number of patients
Fractions
Dose (Gy)
BED10 (Gy)
BED3 (Gy)
8
5
25
37.5
66.7
6
3
21
35.7
70
20
28
46.7
1
24
43.2
88
4
38.4
72
22.5
32.6
56.3
18
28.8
54
26.1
45
2
16
58.7
10
13.2
20.8